May 19th and 20th marked the first definitive meeting between industry leaders to set a common standard for measuring clinical, economical and patient benefits of Medical 3D Printing. An initiative led by Materialise, in partnership with SME, the event on “Building Evidence for 3D Printing Applications in Medicine” was truly a success, and created the building blocks from which the entire 3D Printing industry will benefit.
When you scroll through former posts on this Materialise Medical blog, there are countless examples of the added value of Medical 3D Printing and how the technology is changing the lives of patients everywhere. Those stories make the clinical benefits of 3D Printing clear, and show just how much of an impact this technology has been having on different medical fields. To make it widely available and gain acceptance from hospitals, doctors, users and policymakers, clinical evidence is crucial.